Table 4.
Adverse events—patient characteristics
| Adverse event | No. of patients | Age | Sex | Hernia type | Simultaneous procedures performed | Comorbidities/anticoagulants | Reintervention |
|---|---|---|---|---|---|---|---|
| Urinary retention | 1 | 61 | M | Inguinal-direct | |||
| Surgical emphysema | 1 | 70 | F | Femoral-bilateral | |||
| Groin seroma | 6 | 71 | M | Spigelian | |||
| 72 | M | Inguinoscrotal | AF/dabigatran | ||||
| 43 | M | Inguinal-direct | |||||
| 59 | M | Inguinal-direct | |||||
| 76 | M | Inguinal-indirect |
Cholecystectomy Biological mesh used |
||||
| 51 | F | Femoral | |||||
| Groin hernia recurrence | 1 | 63 | M | Inguinal-indirect | Varicose vein stripping | Recurrence (indirect) at 8 months | Open Lichtenstein repair |
| Lateral port site haematoma | 1 | 77 | M | Inguinal-direct | Umbilical hernia repair | Prostate Ca | |
| Umbilical port site hernia | 2 | 30 | M | Inguinal-indirect | |||
| 54 | M | Inguinal-indirect | |||||
| Lateral port site haemorrhage | 1 | 83 | M | Inguinal-bilateral direct | Mechanical heart valve / warfarin | Laparoscopy-evacuation of haemoperitoneum |